S100B and major depressive disorder: In our study, we examined the relationship between plasma levels of mBDNF and S100B and depression severity, obtained during a randomized, placebo-controlled trial of ketamine in Selective Serotonin Reuptake Inhibitor (SSRI)-resistant MDD.